ACH (Accendra Health) Piotroski F-Score: 3 (As of Jun. 25, 2026) — 40% Below Median


ACH Accendra Health Inc ACH
57 GF Score
Price $3.20
GF Value $5.02
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Accendra Health Piotroski F-Score?

Accendra Health ACH +2.24% 57 Piotroski F-Score is 3 as of Jun. 25, 2026, which is 40% below its 10-year median of 5.00. GuruFocus rates ACH with a GF Score™ of 57/100 and a GF Value™ of $5.02 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 114 Medical Distribution companies, Accendra Health ranks worse than 81.58% on this metric.

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Accendra Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Accendra Health's Piotroski F-Score or its related term are showing as below:

ACH' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 8
Current: 3

During the past 13 years, the highest Piotroski F-Score of Accendra Health was 8. The lowest was 3. And the median was 5.

Accendra Health  (NYSE:ACH) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Accendra Health Piotroski F-Score Related Terms


Accendra Health Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Accendra Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accendra Health Piotroski F-Score Chart

Accendra Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.00 4.00 5.00 4.00 3.00

Accendra Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 4.00 4.00 3.00 3.00

ACH vs EDAP, YI, COSM: Piotroski F-Score Comparison

For the Medical Distribution subindustry, Accendra Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accendra Health Piotroski F-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Accendra Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Accendra Health's Piotroski F-Score falls into.


ACH
57GF Score
Accendra Health Inc ACH
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -869.058 + -150.276 + -56.326 + -6.468 = $-1,082 Mil.
Cash Flow from Operations was 37.61 + -172.52 + 68.186 + -50.077 = $-117 Mil.
Revenue was 681.917 + 697.264 + 708.967 + 627.78 = $2,716 Mil.
Gross Profit was 324.602 + 322.197 + 323.258 + 278.028 = $1,248 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(4856.424 + 4154.545 + 4036.226 + 2451.761 + 2415.982) / 5 = $3582.9876 Mil.
Total Assets at the begining of this year (Mar25) was $4,856 Mil.
Long-Term Debt & Capital Lease Obligation was $1,589 Mil.
Total Current Assets was $589 Mil.
Total Current Liabilities was $1,203 Mil.
Net Income was -31.913 + -12.77 + -296.116 + -24.982 = $-366 Mil.

Revenue was 660.401 + 686.846 + 695.023 + 2632.048 = $4,674 Mil.
Gross Profit was 316.029 + 331.771 + 332.991 + 526.013 = $1,507 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(5207.993 + 5304.004 + 5081.282 + 4656.156 + 4856.424) / 5 = $5021.1718 Mil.
Total Assets at the begining of last year (Mar24) was $5,208 Mil.
Long-Term Debt & Capital Lease Obligation was $2,222 Mil.
Total Current Assets was $2,206 Mil.
Total Current Liabilities was $1,960 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Accendra Health's current Net Income (TTM) was -1,082. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Accendra Health's current Cash Flow from Operations (TTM) was -117. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-1082.128/4856.424
=-0.22282404

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-365.781/5207.993
=-0.07023454

Accendra Health's return on assets of this year was -0.22282404. Accendra Health's return on assets of last year was -0.07023454. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Accendra Health's current Net Income (TTM) was -1,082. Accendra Health's current Cash Flow from Operations (TTM) was -117. ==> -117 > -1,082 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1589.407/3582.9876
=0.44359824

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=2221.547/5021.1718
=0.44243597

Accendra Health's gearing of this year was 0.44359824. Accendra Health's gearing of last year was 0.44243597. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=588.5/1203.104
=0.4891514

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=2206.198/1960.215
=1.12548777

Accendra Health's current ratio of this year was 0.4891514. Accendra Health's current ratio of last year was 1.12548777. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Accendra Health's number of shares in issue this year was 76.432. Accendra Health's number of shares in issue last year was 77.272. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1248.085/2715.928
=0.45954274

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1506.804/4674.318
=0.32235804

Accendra Health's gross margin of this year was 0.45954274. Accendra Health's gross margin of last year was 0.32235804. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2715.928/4856.424
=0.55924442

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=4674.318/5207.993
=0.8975277

Accendra Health's asset turnover of this year was 0.55924442. Accendra Health's asset turnover of last year was 0.8975277. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+1+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Accendra Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 3 mean?
Accendra Health (ACH) has a Piotroski F-Score of 3 as of Jun. 25, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Accendra Health and its competitors. This is 40% below median its historical median of 5.00. Over the past decade, Accendra Health's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Accendra Health ranks #93 out of 114 companies in the Medical Distribution industry, placing it in the top 81.6%.
Is Accendra Health's Piotroski F-Score too high?
Accendra Health's current Piotroski F-Score of 3 is 40% below median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Medical Distribution industry median Piotroski F-Score is 5.00. Accendra Health's value of 3 is 40% below this industry median. Based on the distribution chart, Accendra Health ranks #93 out of 114 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Accendra Health has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Accendra Health's Piotroski F-Score compare to EDAP and YI?
According to the Medical Distribution industry distribution chart, Accendra Health ranks #93 out of 114 companies for Piotroski F-Score. This places Accendra Health in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Accendra Health's value of 3 is 40% below this benchmark. Historically, Accendra Health's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Accendra Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Distribution company?
The median Piotroski F-Score among Medical Distribution companies is 5.00, based on 114 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accendra Health's current Piotroski F-Score of 3 is 40% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Accendra Health and its competitors. For the Medical Distribution industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accendra Health's current Piotroski F-Score is 3, which is 40% below median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accendra Health stock overvalued right now?
Based on GuruFocus' analysis, Accendra Health (ACH) is currently considered Possible Value Trap. The stock's GF Value™ is $5.02, compared to a current price of $3.20 — trading 36.3% below its estimated fair value. The current Piotroski F-Score is 3, which is 40% below median its 10-year median of 5.00 and 40% below the Medical Distribution industry median of 5.00. Accendra Health's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Accendra Health (ACH), the current Piotroski F-Score is 3 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Accendra Health (ACH) Overvalued in 2026?

Based on GuruFocus' analysis, Accendra Health stock appears to be undervalued. The current stock price of $3.20 is trading 36.3% below its estimated GF Value™ of $5.02. GuruFocus considers Accendra Health to be Possible Value Trap.

Key valuation signals for ACH:

  • Piotroski F-Score: 3 (40% below median its 10-year median of 5.00)
  • GF Value™: $5.02 vs. price of $3.20 (36.3% below fair value)
  • GF Score™: 57/100 with 7 warning signs
  • Industry Position: 40% below the Medical Distribution median (#93 of 114)

No single metric tells the full story. See the ACH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Accendra Health Business Description

Other Exchanges 6OM:Germany
Address 10900 Nuckols Road, Suite 400, Glen Allen, VA, USA, 23060
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
57GF Score

Get the complete analysis for ACH

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.20
Price
$5.02
GF Value